gutsandgrowth

Home | About Jay Hochman -Pediatric Gastroenterology Blog | Archives

• Effectiveness of Switch to Subcutaneous Infliximab January 2, 2026 - (0)

  N Mathieu et al. Clin Gastroenterol Hepatol 2025; 23: 2597 – 2606. Open Access! PErsistence and Safety of Subcutaneous Infliximab 1 Year After Switch From Intravenous Route in IBD Patients in REMission Methods: The PEREM (PErsistence, effectiveness and safety of subcutaneous infliximab after switch from intravenous infliximab in IBD patients in REMission) study, a prospective […]

• From Treatment to Cures for Autoimmune Diseases January 1, 2026 - (0)
• Universal Cholesterol Screening: The LEAD Initiative December 31, 2025 - (0)
• Long-Term Outcomes of Surgery For Excessive Drooling December 30, 2025 - (0)
• Video Capsule Endoscopy in VEO-IBD — Is the Juice Worth the Squeeze? December 29, 2025 - (0)

« Older Newer »

Mobile Site | Full Site

Get a free blog at WordPress.com Theme: WordPress Mobile Edition by Alex King.